Sandoz acquires antibiotics production facility

Sandoz acquires antibiotics production facility in Spain

Acquisition strengthens in-house production and adds freeze-drying technology

Vienna, 11 December 2003 - Sandoz, the generics business unit of Novartis, announced today that it has acquired the production plant of Amifarma S.L. in Palafolls, which is located north of Barcelona, Spain, for an undisclosed sum.

Please see full press release under the following link:

Recommended Reading

July 31, 2026 16:25 ET | Source: Novartis Pharma AG

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease

Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient populationPSMAddition updated results show Pluvicto reduced risk of progression or death by 33% in...
Read More
July 21, 2026 01:00 ET | Source: Novartis Pharma AG

Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed

Ad hoc announcement pursuant to Art. 53 LRSecond quarterNet sales grew +1% (cc1, +3% USD), with core operating income1 flat (cc and USD)Sales growth driven by priority brands including Kisqali (+43%...
Read More

Sandoz acquires antibiotics production facility

Tags

Attachments

Recommended Reading